What is ANI Pharmaceuticals's interest expense?

ANI Pharmaceuticals (ANIP) reported interest expense of -$3.77M in Q1 2026.

How has ANI Pharmaceuticals's interest expense changed year-over-year?

ANI Pharmaceuticals's interest expense increased by 31.3% year-over-year, from -$5.48M to -$3.77M.

What is the long-term trend for ANI Pharmaceuticals's interest expense?

Over 4 years (2021 to 2025), ANI Pharmaceuticals's interest expense has grown at a 13.9% compound annual growth rate (CAGR), from -$11.92M to -$20.06M.

What does interest expense mean?

Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.

ANI Pharmaceuticals ANIP Interest Expense

Interest Expense at other companies

Amneal Pharmaceuticals, Inc.AMRX

-$53.36M+6.3%

ViatrisVTRS

$120.1M+4.0%

ALN

Alnylam PharmaceuticalsALNY

$69.29M+18.8%

Aurinia PharmaceuticalsAUPH

$1.01M-5.2%

Viridian Therapeutics, Inc.VRDN

$3.46M+529%

AmgenAMGN

——

Segments

By segment

See full

Generics and Other$0—

Rare Disease and Brands$0—

Other financials

Income statement

See full

Revenue$237.5M+20.5%

Gross profit$143.9M+16.0%

Operating income$38.9M+48.5%

Net income$29.5M+88.1%

EPS (diluted)$1.28+85.5%

Balance sheet

See full

Cash & equivalents$311.2M+108%

Total debt$305.3M-3.5%

Total equity$562.3M+34.3%

Total assets$1.4B+10.0%

Cash flow

See full

Operating cash flow$58.4M+66.8%

CapEx$6.1M+146%

Free cash flow$52.3M+60.8%

Valuation

See full

Market cap$1.89B+18.3%

Enterprise value$1.88B+5.8%

P/E20.5×—

P/S2×-0.3×

Profitability

See full

Gross margin60.8%+1.5pp

Operating margin13.4%—

Net margin10%+8.1pp

FCF margin20.7%+10.8pp

Returns & leverage

See full

Return on equity18.8%+15.6pp

Debt / equity0.5×-0.2×

Current ratio3.1×+0.5×

Where this comes from

Reported directly by ANI Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.

The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about ANI Pharmaceuticals's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ANI Pharmaceuticals's interest expense?: ANI Pharmaceuticals (ANIP) reported interest expense of -$3.77M in Q1 2026.
How has ANI Pharmaceuticals's interest expense changed year-over-year?: ANI Pharmaceuticals's interest expense increased by 31.3% year-over-year, from -$5.48M to -$3.77M.
What is the long-term trend for ANI Pharmaceuticals's interest expense?: Over 4 years (2021 to 2025), ANI Pharmaceuticals's interest expense has grown at a 13.9% compound annual growth rate (CAGR), from -$11.92M to -$20.06M.
What does interest expense mean?: Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.